Duos Technologies Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Duos Technologies Group (DUOT).

Price Target Range — 9 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingOutperform# Analysts3Avg. Consensus PT$22Upside to Avg. PT+173.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$22→$24
Aug 18, 2026	Cantor Fitzgerald	Brett Knoblauch	PT Raise	Overweight	$26→$27
Jul 31, 2026	Cantor Fitzgerald	Brett Knoblauch	Initiate	Overweight	$26
Jun 15, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$17→$22
Apr 17, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$14→$17
Dec 30, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$12→$14
Sep 24, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$11→$12
Jun 16, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$9→$11
Apr 28, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$8→$9
Feb 5, 2025	Northland Capital Markets	Michael Latimore	PT Raise	Outperform	$10→$14
Dec 17, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$6→$8
Nov 22, 2024	Northland Capital Markets	Michael Latimore	PT Raise	Outperform	$6→$10
Sep 11, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$6→$6
Jun 7, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$6→$6

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $24

Ascendiant Capital analyst Edward Woo maintains Duos Technologies Group (NASDAQ:DUOT) with a Buy and raises the price target from $22 to $24.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Duos Technologies Group, Raises Price Target to $27

Cantor Fitzgerald analyst Brett Knoblauch maintains Duos Technologies Group (NASDAQ:DUOT) with a Overweight and raises the price target from $26 to $27.

Benzinga Newsdesk

This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, initiations. See other analysts' views on HTFL, SKYH, FTH.

Avi Kapoor

PRO
Cantor Fitzgerald Initiates Coverage On Duos Technologies Group with Overweight Rating, Announces Price Target of $26

Cantor Fitzgerald analyst Brett Knoblauch initiates coverage on Duos Technologies Group (NASDAQ:DUOT) with a Overweight rating and announces Price Target of $26.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $22

Ascendiant Capital analyst Edward Woo maintains Duos Technologies Group (NASDAQ:DUOT) with a Buy and raises the price target from $17 to $22.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $17

Ascendiant Capital analyst Edward Woo maintains Duos Technologies Group (NASDAQ:DUOT) with a Buy and raises the price target from $14 to $17.

Benzinga Newsdesk

Duos Technologies Group Inc

Duos Technologies Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $24

PRO
Cantor Fitzgerald Maintains Overweight on Duos Technologies Group, Raises Price Target to $27

This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

PRO
Cantor Fitzgerald Initiates Coverage On Duos Technologies Group with Overweight Rating, Announces Price Target of $26

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $22

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $17

People Also Watch

People Also Watch

Duos Technologies Group Inc

Duos Technologies Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROAscendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $24

PROCantor Fitzgerald Maintains Overweight on Duos Technologies Group, Raises Price Target to $27

This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

PROCantor Fitzgerald Initiates Coverage On Duos Technologies Group with Overweight Rating, Announces Price Target of $26

PROAscendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $22

PROAscendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $17

People Also Watch

People Also Watch

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $24

PRO
Cantor Fitzgerald Maintains Overweight on Duos Technologies Group, Raises Price Target to $27

PRO
Cantor Fitzgerald Initiates Coverage On Duos Technologies Group with Overweight Rating, Announces Price Target of $26

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $22

PRO
Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $17